Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Ruprecht: Confirming the Efficacy of Virosomes Targeting gp41 in Indian Rhesus Macaques |
| Strategy: | Combo: Vector & VLP vaccines |
| Study Type: | Pre-Clinical NHP |
| Species: | Rhesus macaque |
| Stage: | Assays Completed |
| Study Start Date: | 2016-08-22 |
| Study Made Public: | 2018-07-20 |
Title
Confirming the Efficacy of Virosomes Targeting gp41 in Indian Rhesus Macaques
Description
CAVD 608 is a non-human primate challenge study comparing virosome combination regimens.
Sign in to see full information about this study and to download study data.
Products
Virosome-P1 Virosome-rgp41 Placebo virosome Inactivated influenza (unspecified) SHIV-SF162P3Integrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.